Long-term efficacy, safety data for ixekizumab in pediatric psoriasis reportedApril 25, 2022PsoriasisPsoriatic ArthritisPediatrics
Experts decry CDC’s long pause on neglected tropical disease testingApril 25, 2022Infectious Diseases
Three in four U.S. doctors are employed by hospitals, corporate entities: ReportApril 25, 2022Business of Medicine
Secukinumab’s antipsoriatic effects confirmed in U.S. patient populationApril 25, 2022Psoriatic ArthritisPsoriasis
Age, skin cancer risks for ICI-induced bullous pemphigoid identifiedApril 22, 2022MelanomaMedical Dermatology
